Skip to Main content Skip to Navigation
Journal articles

Hepatic molecular signatures highlight the sexual dimorphism of Non-Alcoholic SteatoHepatitis (NASH)

Abstract : Non-Alcoholic SteatoHepatitis (NASH) is considered as a pivotal stage in Non-Alcoholic Fatty Liver Disease (NAFLD) progression, as it paves the way for severe liver injuries such as fibrosis and cirrhosis. The etiology of human NASH is multi-factorial and identifying reliable molecular players and/or biomarkers has proven difficult. Together with the inappropriate consideration of risk factors revealed by epidemiological studies (altered glucose homeostasis, obesity, ethnicity, sex…), the limited availability of representative NASH cohorts with associated liver biopsies, the gold standard for NASH diagnosis, probably explains the poor overlap between published "omics"-defined NASH signatures.
Document type :
Journal articles
Complete list of metadatas

Cited literature [73 references]  Display  Hide  Download

https://www.hal.inserm.fr/inserm-02617094
Contributor : Marie-Hélène Derudas <>
Submitted on : Monday, May 25, 2020 - 10:12:11 AM
Last modification on : Thursday, November 19, 2020 - 4:56:17 PM

File

Vandel_et_al_main_text_version...
Files produced by the author(s)

Identifiers

Collections

Citation

Jimmy Vandel, Julie Dubois-Chevalier, Celine Gheeraert, Bruno Derudas, Violetta Raverdy, et al.. Hepatic molecular signatures highlight the sexual dimorphism of Non-Alcoholic SteatoHepatitis (NASH). Hepatology, Wiley-Blackwell, 2020, ⟨10.1002/HEP.31312⟩. ⟨inserm-02617094⟩

Share

Metrics

Record views

70

Files downloads

1